CVS Health announced the addition of four new board members, including Glenview Capital Management CEO Larry Robbins, following an agreement with the hedge fund. This move comes as Glenview increased its stake in CVS by 31% during the third quarter, purchasing 2.8 million shares. CVS chairman Roger Farah emphasized the goal of delivering greater value to all stakeholders through this collaboration, expanding the board to a total of 16 members.